Skip to contentP
Petmed Express Inc
P
PETSPetmed Express Inc Q4 2022 · 10-K
Revenue$65.85M$65.85M−8.1% vs Q4 2021 Net Income$5.54M$5.54M−18.7% vs Q4 2021 EPS Diluted$0.30$0.30−11.8% vs Q4 2021 Gross Profit$19,397,000−5.5% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Petmed Express Inc · CIK 1040130 · Engraved from SEC EDGAR
Operating Cash Flowderived$8,717,000−52.8% Free Cash Flowderived$8,231,000−53.9% Margins · derivedGross margin29.5%+0.8 pt vs Q4 2021
Operating margin10.7%−1.0 pt vs Q4 2021
Net margin8.4%−1.1 pt vs Q4 2021
ended Mar 31, 2022 · filed May 24, 2022 · 54 d after period end